CELG News 147.65 05/21/2014 04:34:16 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 147.65 $CELG

AADi signs licensing agreement with Celgene for nanotechnology-based drug candidate ABI-009
M2 - 31 mins ago
Biopharmaceutical company AADi stated on Tuesday that it has entered into an agreement to license the nanotechnology drug candidate ABI-009 from Celgene (NasdaqGS:CELG).

Biotech Tweet of the Week: Share Buybacks
Brian Orelli, The Motley Fool - Motley Fool - Tue May 20, 5:30PM CDT
We've got a pair of related tweets on this week's episode of Biotech Banter . The first is from Jason Napodano, an analyst at Zacks, who asks, "Does anyone actually finish a share buyback in biotech, or do they just announced another one after they...

Final Glance: Biotechnology companies
AP - Tue May 20, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Midday Glance: Biotechnology companies
AP - Tue May 20, 12:44PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

FDA Designation for Bristol-Myers/AbbVie Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 20, 10:40AM CDT
Bristol-Myers (BMY) and AbbVie (ABBV) announced that the FDA has granted breakthrough therapy designation to elotuzumab.

Early Glance: Biotechnology companies
AP - Tue May 20, 9:40AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

AADi Announces Licensing Agreement with Celgene for Nanotechnology-Based Drug Candidate
PR Newswire - Tue May 20, 8:00AM CDT
AADi, LLC, a clinical stage biopharmaceutical company focused on treating diseases uniquely suited for nanotechnology approaches, today announced the inlicensing of ABI-009 from Celgene Corporation (NASDAQ:CELG). ABI-009 is the nanoparticle albumin-bound (nab®) version of the mTOR inhibitor sirolimus or rapamycin and leverages the same technology of the nab® platform that is behind the success of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound).

Celgene Corporation to Present at Investor Conferences in June
Business Wire - Tue May 20, 7:30AM CDT
Celgene Corporation (NASDAQ:CELG) announced that Celgene management will provide an overview of the Company at three upcoming investor conferences in the month of June. The conferences will be webcast live and a link to the webcasts will be available in the Investor Relations section of the Company's website at www.celgene.com.

Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
GlobeNewswire - Mon May 19, 7:05AM CDT
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ), and CRD Analytics today announced the results of the semi-annual re-ranking of the NASDAQ OMX CRD Global Sustainability Index (Nasdaq:QCRD), which will become effective prior to market open on Monday, May 19, 2014.

3 Companies Frightened by This Medicare Study
Todd Campbell, The Motley Fool - Motley Fool - Sun May 18, 6:05AM CDT
Everyone knows that medical costs are soaring, and that those costs present one of the biggest financial challenges to the next generation. But far fewer know that one of the biggest drug buyers, the Centers for Medicare and Medicaid Services, or...

After Yesterday's Decline of 1.03%, Celgene Offers Investors Better Value
Comtex SmarTrend(R) - Fri May 16, 3:52PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $145.30 to a high of $150.20. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $148.00 on volume of 2.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for Celgene to Potentially Rebound After Falling 1.03% Yesterday
Comtex SmarTrend(R) - Fri May 16, 3:51PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $145.30 to a high of $150.20. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $148.00 on volume of 2.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation
PR Newswire - Fri May 16, 6:00AM CDT
Today, Analysts Review released its analysts' notes regarding Celgene Corporation (NASDAQ: CELG), Biogen Idec Inc. (NASDAQ: BIIB), Incyte Corporation (NASDAQ: INCY), Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and Medivation Inc. (NASDAQ: MDVN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2548-100free.

Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2014
Business Wire - Wed May 14, 4:19PM CDT
Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced more than 65 abstracts reporting on investigational studies in blood and solid tumor cancers will be presented during the 50th American Society of Clinical Oncology meeting in Chicago, Ill. from May 30 to June 3, 2014.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

A Journey Through Mongolia's Wilderness and Self-Discovery

Updated Category News Views 105

A Late-Life Adventure Without Borders We all hit that age where adventure seems just a memory—until something shakes us from our slumber, just like Betsy Cooksey’s wild ride into Mongolia. At an age when most tether their dreams to sunlit porches and grandkids' photos, Cooksey grabbed life by the reins. First, though, we gotta talk about the absolute gamble she took....

Continue Reading
Intensity Therapeutics: Q3 Results Show Steady Progress

Updated Category News Views 24

Patient Enrollment Back on Track Today feels like we're talking about a company that's finally shaking off the cobwebs—Intensity Therapeutics is back in action with their cancer trials. After hitting the brakes back in March 2025 thanks to a cash crunch, it looks like Intensity is revving up once more, thanks to some better financial footing. They've got their Phase 3...

Continue Reading
Pavlus Travel's Bucket-List Trips in High Demand for 2027

Updated Category News Views 46

Luxury Travel is Having a Moment A fancy vacation isn't just a postcard on the wall anymore—it's now, more than ever, a box folks are itching to check off their lists. Call it a midlife shift or just the world shrugging off its pandemic blues, but high-end travelers are saying, "The time is now," and they're serious. Pavlus Travel, a top name in the lux travel space,...

Continue Reading
Inside HVAC Installations: Keys to Efficiency & Comfort

Updated Category News Views 83

Unpacking the HVAC Replacement Process I'll tell you what, you never think much about heating or air conditioning until they're not doing their job. Anyone who's sweated through a summer or shivered through a winter knows the agony. But here comes an article that finally sheds light on what really goes down during an HVAC system replacement, with some good nuggets from...

Continue Reading
Fluence Energy Faces Securities Lawsuit; Investors Alerted

Updated Category News Views 29

Fluence Energy Tied Up in Legal Quagmire Well, here we go again. Fluence Energy, Inc. (NASDAQ: FLNC) finds itself smack in the middle of a legal mess. The DJS Law Group has sounded the alarm on a class action lawsuit that's got investors and traders alike on edge. With allegations of securities law violations, this ain't pretty for Fluence or its shareholders. The class...

Continue Reading
Bluevua Triumphs with Three BASA Awards Wins

Updated Category News Views 48

Bluevua Sweeps the 2026 BASA Awards Stacking accolades like old trading wins, Bluevua just clinched not one, not two, but three 2026 Best of America Small Business Awards (BASA Awards®). If that's not a feather in their cap, I don't know what is. For the uninitiated, these BASA nods are no small potatoes—they're like the Oscars for small businesses. Bluevua, known for...

Continue Reading
Stephen Holowesko Joins JonesTrading's Outsourced Team

Updated Category News Views 131

Revving Up Trading Prowess Back in the day, adding a big shot to your team seemed all about bolstering the company's brag sheet. Nowadays, moves like those by JonesTrading are a clear-eyed response to growing demands. They're doubling down on Outsourced Trading with the likes of Stephen Holowesko stepping in as Managing Director. The firm clearly sees this as a linchpin...

Continue Reading
Unlikely Collaborators Grants $7.2M to Boost Nonprofits

Updated Category News Views 82

Massive Boost for Nonprofits Across the United States It's not every day you see millions thrown into nonprofit work without some fanfare, right? Unlikely Collaborators just poured a hefty $7.2 million into the coffers of 52 nonprofit outfits scattered across the nation. This spread isn't just about slapping cash on projects—it's about putting Elizabeth R. Koch's...

Continue Reading
LV Petroleum Hits Major Expansion Milestone Nationwide

Updated Category News Views 55

LV Petroleum Revvs Up with Nationwide Growth This ain't your granddad's pit stop anymore. With LV Petroleum hitting the big 100 mark in travel centers, we're not just talking fuel and snacks here. Over the past 14 months, they bulked up from 42 sites to this triple-digit milestone. That's putting the pedal to the metal, no doubt. What's in it for Drivers and Communities...

Continue Reading
TagniFi Spread: AI Transforming Financial Analysis

Updated Category News Views 40

Ah, finance folks, we've all been there—lost in the trenches, teeth gritted as we manually grind through private company financials. It's like trying to piece together a 1,000-piece jigsaw puzzle without a picture of the final scene. But now, someone's come along and flipped on the light switch. Enter TagniFi Spread, the new AI-powered tool that's snapped a whole lot of...

Continue Reading

Top 5 Most Recently Viewed Articles

ATRenew's Remarkable Q4 and Full Year 2024 Financial Growth

Updated Category News Views 207

ATRenew Inc. Financial Overview ATRenew Inc. (NYSE: RERE), a technology-driven platform specializing in pre-owned consumer electronics, recently shared its remarkable financial results for the fourth quarter and the entire year of 2024. Fourth Quarter Achievements In the fourth quarter of 2024, ATRenew experienced a significant revenue increase of 25.2%, reaching...

Continue Reading
Elevate Your Gaming Experience with Betblast’s New Features

Updated Category News Views 254

Unveiling the New Betblast Features for Gamers In a digital age where online gambling is immensely popular, players are consistently on the lookout for platforms that provide more than just entertainment but also real, significant rewards. One name that has emerged as a favorite among players for offering exceptional wins and rapid payouts is Betblast. As discussions...

Continue Reading
Unifiedpost Group's Invitation to Upcoming Shareholders Meeting

Updated Category News Views 269

Invitation to Extraordinary and Ordinary General Meeting UNIFIEDPOST GROUP Public limited liability company under Belgian law Registered office at Avenue Reine Astrid 92A, 1310 La Hulpe, Belgium Company number 0886.277.617 The Board of Directors of Unifiedpost Group SA/NV (the Company) invites shareholders and warrant holders to attend the Extraordinary and Ordinary

Continue Reading
Transform Your Investment: Arthur J. Gallagher's 5-Year Growth

Updated Category News Views 86

Arthur J. Gallagher’s Five-Year Run, In Plain View Arthur J. Gallagher (NYSE: AJG) has delivered standout results over the past five years. Its annualized return of 27.83% didn’t just keep pace with the market—it beat it by 15.0 percentage points per year. That kind of steady outperformance is rare, and it’s exactly what long-term investors hope to find....

Continue Reading
FFG Asset Management Integrates DTCC’s ITP for Financial Efficiency

Updated Category News Views 86

FFG Asset Management Embraces DTCC's ITP Services In recent developments within the global financial market infrastructure, FFG Asset Management (FFG AM) has taken a significant step by adopting the Institutional Trade Processing (ITP) services offered by the Depository Trust & Clearing Corporation (DTCC). This partnership marks a crucial move towards innovative,...

Continue Reading